Increased ischemic stroke, acute coronary artery disease and mortality in patients with granulomatosis with

M Mourguet1, D Chauveau2, S Faguer2

  • 1Université de Toulouse Paul Sabatier, Toulouse, France; Service de Médecine Interne, CHU Toulouse Purpan, Toulouse, France.

Journal of Autoimmunity
|September 22, 2018
PubMed

Insights

Patients with ANCA-associated vasculitis (AAV) face significantly higher risks of major cardiovascular events, including ischemic stroke and coronary artery disease. Mortality rates are also elevated in AAV patients compared to the general population.

Area of Science:

  • Cardiovascular Medicine
  • Rheumatology
  • Epidemiology

Background:

  • ANCA-associated vasculitis (AAV) encompasses severe systemic autoimmune diseases.
  • Cardiovascular complications represent a significant cause of morbidity and mortality in AAV patients.
  • Understanding cardiovascular event incidence and predictors in AAV is crucial for patient management.

Purpose of the Study:

  • To evaluate the incidence of major cardiovascular events (MCEs) in patients diagnosed with Granulomatosis with Polyangiitis (GPA) or Microscopic Polyangiitis (MPA).
  • To identify predictors associated with cardiovascular disease occurrence in AAV.
  • To assess the overall mortality risk in AAV patients.

Main Methods:

  • Retrospective cohort study of GPA and MPA patients diagnosed between 1981 and 2015.
  • MCEs defined as acute coronary artery disease, ischemic stroke, or revascularization for peripheral vascular disease.
  • Cox proportional hazards regression models were used to analyze risk factors for cardiovascular events and mortality.

Main Results:

  • Ischemic stroke and coronary artery disease incidence were approximately four times higher in AAV patients than in the general population.
  • Smoking and prior coronary artery disease history were significant risk factors for coronary artery disease.
  • Overall mortality was 1.5 times higher in AAV patients compared to the general population.

Conclusions:

  • ANCA-associated vasculitis is associated with a substantially increased risk of mortality, ischemic stroke, and coronary artery disease.
  • Proactive cardiovascular risk management is essential for patients with AAV.
  • Further research into protective factors, such as ENT flare-ups, may offer therapeutic insights.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
471
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
273
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
383
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
696
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.0K